259.6700 -1.78 (-0.68%)
NSE Jun 19, 2026 15:31 PM
Volume: 2.4M
 

259.67
-0.68%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Marksans Pharma has gained 42.04% in the last 6 Months
More from Marksans Pharma Ltd.
Recommended